Notch Regulation of Hematopoietic Cell Fates
Notch Regulation of Hematopoietic Cell Fates
批准号:
10335128
负责人:
MARTHA S JORDAN
金额:
$45.5万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-08-01 至 2024-01-31
关键词:
Adoptive TransferAgonistAntibody FormationAntigensB-LymphocytesBindingCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCell CompartmentationCell Differentiation processCell physiologyCellsChronicDataExhibitsExposure toGoalsHematopoieticImmuneImmune responseIn VitroInfectionInterleukin-2KnowledgeLeadLymphocytic choriomeningitis virusMalignant NeoplasmsMediatingMolecularMucosa- associated lymphoid tissue lymphoma translocation protein-1MusNaturePathway interactionsPhaseProgressive DiseaseProliferatingProteinsRegulationRegulatory PathwayResearchResolutionRoleSignal PathwaySignal TransductionStructureT cell differentiationT cell responseT cell therapyT-Cell ActivationT-Cell ReceptorT-LymphocyteTNF geneTestingTherapeuticTherapeutic InterventionViraladaptive immune responsearmbasechronic infectioncytokineeffector T cellexhaustexhaustionimproved outcomein vivoinsightnotch proteinnovelnovel therapeutic interventionprotein degradationresponsetherapeutic targettranscription factor
中文摘要
T细胞在适应性免疫反应中起着关键作用。然而,当连续
英文摘要
T cells are pivotal players in the adaptive immune response. However, when continuously
exposed to antigen, as in persistent infection or cancer, T cells lose effector function and
ultimately become exhausted, leading to chronic infection or progressive disease. Recent
therapeutic advances are based on reversing these natural mechanisms set in place to “quiet”
activated T cells during the resolution phase of an immune response, and in doing so,
reinvigorate immune responses crippled by T cell exhaustion. However, response rates remain
low in many settings; thus, additional strategies are needed. Crucial for developing such
strategies is to identify new targetable pathways, which is currently hampered by our limited
basic knowledge of the negative regulatory pathways that inhibit T cell activation.
We recently discovered that the pseudokinase Trib1 is a novel negative regulator of T cell
activation, which is induced upon T cell receptor (TCR) stimulation. Our overall goal is to
determine the cellular and molecular mechanisms by which Trib1 regulates T cell responses.
Our preliminary data generated both in vitro and in vivo suggest that in the absence of Trib1, T
cells are hyper-activated and are better able to control chronic infections. Mechanistically, Trib1
appears to exert its effects on T cells via a novel mechanism of regulating NF-κB. Based on
these preliminary data, our overarching hypothesis is that Trib1 suppresses signaling pathways
that promote T cell activation and promotes immune cell exhaustion by limiting T cell effector
function and B cell help. This hypothesis will be tested in two aims: Aim 1 will define the cellular
responses regulated by Trib1, and Aim 2 will determine the signaling pathways responsible for
these findings. Our findings may lead to new insights into controlling T cell activation and
exhaustion in multiple scenarios, including chronic infections and cancer, and in doing so,
identify new avenues for therapeutic interventions.
期刊论文(38)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1371/journal.pone.0030656
发表时间:
2012
期刊:
PloS one
影响因子:
3.7
作者:
[Pan X, Jones M, Jiang J, Zaprazna K, Yu D, Pear W, Maillard I, Atchison ML]
通讯作者:
Atchison ML
The transcriptional coactivator Maml1 is required for Notch2-mediated marginal zone B-cell development.
Notch2 介导的边缘区 B 细胞发育需要转录共激活因子 Maml1。
DOI:
10.1182/blood-2007-06-097030
发表时间:
2007
期刊:
Blood
影响因子:
20.3
作者:
[Wu,Lizi, Maillard,Ivan, Nakamura,Makoto, Pear,WarrenS, Griffin,JamesD]
通讯作者:
Griffin,JamesD
DOI:
10.1038/leu.2011.127
发表时间:
2011-10
期刊:
Leukemia
影响因子:
11.4
作者:
[Pajcini KV, Speck NA, Pear WS]
通讯作者:
Pear WS
DOI:
10.1146/annurev-pathol-052016-100127
发表时间:
2017-01-24
期刊:
Annual review of pathology
影响因子:
--
作者:
[Aster JC, Pear WS, Blacklow SC]
通讯作者:
Blacklow SC
DOI:
10.1016/j.str.2016.03.002
发表时间:
2016-05-03
期刊:
Structure (London, England : 1993)
影响因子:
--
作者:
[Uljon S, Xu X, Durzynska I, Stein S, Adelmant G, Marto JA, Pear WS, Blacklow SC]
通讯作者:
Blacklow SC
共 16 条
Transcriptional Checkpoints Of Autoimmune Encephalomyelitis
-
批准号:10521303
-
项目类别:
-
资助金额:$50.12万
-
财政年份:2019
-
负责人:MARTHA S JORDAN
-
依托单位:
The role of SLP-76 phosphorylation in T cell development
-
批准号:7270073
-
项目类别:
-
资助金额:$12.76万
-
财政年份:2006
-
负责人:MARTHA S JORDAN
-
依托单位:
The role of SLP-76 phosphorylation in T cell development
-
批准号:7485035
-
项目类别:
-
资助金额:$12.76万
-
财政年份:2006
-
负责人:MARTHA S JORDAN
-
依托单位:
The role of SLP-76 phosphorylation in T cell development
-
批准号:8123426
-
项目类别:
-
资助金额:$12.76万
-
财政年份:2006
-
负责人:MARTHA S JORDAN
-
依托单位:
The role of SLP-76 phosphorylation in T cell development
-
批准号:7147801
-
项目类别:
-
资助金额:$12.76万
-
财政年份:2006
-
负责人:MARTHA S JORDAN
-
依托单位:
The role of SLP-76 phosphorylation in T cell development
-
批准号:7660322
-
项目类别:
-
资助金额:$12.76万
-
财政年份:2006
-
负责人:MARTHA S JORDAN
-
依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
-
批准号:32000851
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:乔安娜
-
依托单位: